Pharmacotherapy in autism spectrum disorders, including promising older drugs warranting trials

Available pharmacotherapies for autism spectrum disorders (ASD) are reviewed based on clinical and research experience, highlighting some older drugs with emerging evidence. Several medications show efficacy in ASD, though controlled studies in ASD are largely lacking. Only risperidone and aripipraz...

Descripción completa

Detalles Bibliográficos
Autor principal: Hellings, Jessica
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2023
Materias:
Opinion Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10294139/
https://www.ncbi.nlm.nih.gov/pubmed/37383284
http://dx.doi.org/10.5498/wjp.v13.i6.262

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10294139/
https://www.ncbi.nlm.nih.gov/pubmed/37383284
http://dx.doi.org/10.5498/wjp.v13.i6.262

Ejemplares similares